---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-010188"
form_type: "8-K"
ticker: "PTN"
cik: "0000911216"
company_name: "PALATIN TECHNOLOGIES INC"
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T05:26:28.684881+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# Palatin partners with UpScriptHealth to expand Vyleesi access via telehealth platform

## Summary
- Palatin (PTN) entered strategic partnership with telemedicine company UpScriptHealth.
- Vyleesi, the first FDA-approved as-needed HSDD treatment, will be on UpScriptHealth's Women's Telehealth Platform.
- UpScriptHealth's patient base is hundreds of thousands of women; partnership aims to boost HSDD awareness.
- Palatin CEO Carl Spana said the deal fortifies existing telehealth programs and expands patient access.

## SEC filing metadata
- accession: 0001654954-23-010188
- form_type: 8-K
- ticker: PTN
- cik: 0000911216
- company_name: PALATIN TECHNOLOGIES INC
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/911216/000165495423010188/0001654954-23-010188-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/911216/000165495423010188/ptn_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-010188
- JSON: https://secwatch.observer/filing/0001654954-23-010188.json
- Plain text: https://secwatch.observer/filing/0001654954-23-010188.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.